ArticleJournal of gastrointestinal oncology2026
Persistent FGFR pathway dependence: where does tinengotinib fit after FGFR inhibitor therapy in advanced cholangiocarcinoma?
Hideki Sasanuma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.